Anti-C170 [NCRC22]

Colorectal carcinoma is one of the most common malignant neoplasms. The cell line C170 was derived directly from a human primary tumor and as such was used as an immunogen to generate an antibody which is able to detect an epitope of a variety of colorectal cancerous cell lines.

Contributors

Inventor Institute
Lindy Durrant University of Nottingham
Cat. #: 152937
Provenance and Ownership: The Anti-C170 [NCRC22] is owned by Cancer Research UK. CancerTools supplies the Anti-C170 [NCRC22] under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing Anti-C170 [NCRC22] directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements.
Tool sub type: Primary antibody
Unit size: 100 ug
Research Fields: Cancer;Cell biology;Tags and cell markers
Application: ELISA ; FACS
Target: C170 – Colorectal carcinoma cell line
Reactivity: Human
Clone: [NCRC22]
Host: Mouse
Class: Monoclonal
Product description: Colorectal carcinoma is one of the most common malignant neoplasms. The cell line C170 was derived directly from a human primary tumor and as such was used as an immunogen to generate an antibody which is able to detect an epitope of a variety of colorectal cancerous cell lines.
Conjugation: Unconjugated
Isotype: IgG1
Immunogen: C170 cells
Myeloma used: P3NSI-Ag-1
Target background: Colorectal carcinoma is one of the most common malignant neoplasms. The cell line C170 was derived directly from a human primary tumor and as such was used as an immunogen to generate an antibody which is able to detect an epitope of a variety of colorectal cancerous cell lines.
Format: Liquid
Concentration: 0.9-1.1 mg/ml
Storage buffer: PBS with 0.02% azide
Storage conditions: -15° C to -25° C
Shipping conditions: Dry ice
References:

Durrant et al. 1986. Br J Cancer. 53(1):37-45. PMID: 3947514.

Antigenicity of newly established colorectal carcinoma cell lines.

Related Tools for Antibodies

Cat. # Tool Name
151027 Anti-HSVICP8 [10A3] Key Info View Tool
151020 Anti-CyclinB1 [V143.1] Key Info View Tool
151026 Anti-FCGR1 [10.1] mAb Key Info View Tool
151039 Anti-Integrin aVb3 [23C6] Key Info View Tool
151018 Anti-Mos [R38.1] Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.